Developing Ex Vivo Models in Breast and Lung Cancer

An ACED Research Project Exemplar

Developing Ex Vivo Models in Breast and Lung Cancers


Prof Sarah CartmellProf Alberto Saiani, Dr Andrew Gilmore


Project Summary

This infrastructure award is focusing on developing our ability to develop human-derived models representing at risk normal tissue or early malignant lesions for study cancers such as breast and lung cancer. These models will explore the process of cancer initiation and open up new mechanisms for identifying the earliest stages of cancer transformation and biomarkers. This capacity once tested will provide a testbed with which can be used for research models of other cancers ex vivo.



Research Themes

Navigate back to read about the other Research Themes and projects

About ACED Manchester

ACED is a £55 million partnership between world-leading early detection institutes and organisations dedicated to improving the early detection of cancer.

Funding Opportunities

Discover the opportunities for ACED Member organisations to lever additional ACED funding in strategic areas.